Inventor · disambiguated record
Nalini Sathyanarayan
Also filed as: SATHYANARAYAN NALINI
5 granted patents·1 pending application·56 citations·filing 2014–2017
82Inventor score
Technology areasA61P
Files withIMMUNOMEDICS INC6
Top patents by PatentIndex Score
6 records- 0195US8877202B2Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2014·Granted Nov 4, 2014·27 cites·45 claims
- 0293US9694088B2Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2016·Granted Jul 4, 2017·11 cites·25 claims
- 0391US9486536B2Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2016·Granted Nov 8, 2016·7 cites·24 claims
- 0488US9283286B2Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2015·Granted Mar 15, 2016·5 cites·16 claims
- 0587US9095628B2Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2014·Granted Aug 4, 2015·6 cites·23 claims
- 0661US2017266310A1Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancerIMMUNOMEDICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nalini Sathyanarayan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →